Patient‐reported outcomes of blue‐light flexible cystoscopy with hexaminolevulinate in the surveillance of bladder cancer: results from a prospective multicentre study
暂无分享,去创建一个
Sanjay G. Patel | Y. Lotan | S. Daneshmand | A. Kamat | M. Schoenberg | M. Woods | T. Bivalacqua | Angela B Smith | B. Konety | E. Trabulsi | M. O'Donnell | T. Downs | Jennifer M. Taylor | M. Resnick | K. Pohar | J. Decastro | G. Steinberg | William C. Huang | Jeffrey Jones | J. Jones
[1] Paul K J Han,et al. Distress Due to Prognostic Uncertainty in Palliative Care: Frequency, Distribution, and Outcomes among Hospitalized Patients with Advanced Cancer. , 2018, Journal of palliative medicine.
[2] Sanjay G. Patel,et al. Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter Study , 2017, The Journal of urology.
[3] S. Selph,et al. Comparative Effectiveness of Fluorescent Versus White Light Cystoscopy for Initial Diagnosis or Surveillance of Bladder Cancer on Clinical Outcomes: Systematic Review and Meta‐Analysis , 2017, The Journal of urology.
[4] John D Seigne,et al. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA/SUO Guideline. , 2016, The Journal of urology.
[5] D. Cella,et al. Clinical validity of PROMIS Depression, Anxiety, and Anger across diverse clinical samples. , 2016, Journal of clinical epidemiology.
[6] L. Price,et al. Patient-Reported Outcomes Measurement Information System (PROMIS) instruments among individuals with symptomatic knee osteoarthritis: a cross-sectional study of floor/ceiling effects and construct validity , 2015, BMC Musculoskeletal Disorders.
[7] Jingwei Wu,et al. Operating characteristics of PROMIS four-item depression and anxiety scales in primary care patients with chronic pain. , 2014, Pain medicine.
[8] R. Gershon,et al. Setting standards for severity of common symptoms in oncology using the PROMIS item banks and expert judgment , 2014, Quality of Life Research.
[9] Grace Chen,et al. Patients with chronic pain. , 2013, The Medical clinics of North America.
[10] Dieter Jocham,et al. Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data. , 2013, European urology.
[11] E. Jonasch,et al. Illness uncertainty and quality of life of patients with small renal tumors undergoing watchful waiting: a 2-year prospective study. , 2013, European urology.
[12] Amy P Abernethy,et al. Recommendations for incorporating patient-reported outcomes into clinical comparative effectiveness research in adult oncology. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[13] D. Sargent,et al. Was it worth it (WIWI)? Patient satisfaction with clinical trial participation: Results from North Central Cancer Treatment Group (NCCTG) phase III trial N0147. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] D. Sargent,et al. Quality of life (QOL) for patients treated with FOLFOX with or without cetuximab (Cmab) following complete resection of colorectal cancer (CRC): Results from North Central Cancer Treatment Group (NCCTG) phase III trial N0147. , 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] A. Stone,et al. Standardizing patient-reported outcomes assessment in cancer clinical trials: a patient-reported outcomes measurement information system initiative. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] S. Edge,et al. AJCC Cancer Staging Handbook, 6th edition , 2002 .